Innate Pharma
IPHA
#8563
Rank
S$0.21 B
Marketcap
$2.31
Share price
1.20%
Change (1 day)
-37.97%
Change (1 year)

Market capitalization of Innate Pharma (IPHA)

Market cap: S$0.21 Billion

As of January 2025 Innate Pharma has a market cap of S$0.21 Billion. This makes Innate Pharma the world's 8563th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Innate Pharma from 2006 to 2025

End of year Market Cap

Year Marketcap Change
2025S$0.21 B-10.96%
2024S$0.23 B-21.89%
2023S$0.30 B-24.19%
2022S$0.40 B-25.94%
2021S$0.54 B21.71%
2020S$0.44 B-37.27%
2019S$0.70 B-4.64%
2018S$0.74 B70.77%
2017S$0.43 B-63.83%
2016S$1.20 B6.88%
2015S$1.12 B67.69%
2014S$0.67 B69.43%
2013S$0.39 B197.9%
2012S$0.13 B99.82%
2011S$66.62 M-11.48%
2010S$75.27 M-58.7%
2009S$0.18 B156.04%
2008S$71.19 M-46.15%
2007S$0.13 B-39.63%
2006S$0.21 B

End of Day market cap according to different sources

On Jan 17th, 2025 the market cap of Innate Pharma was reported to be:

S$0.18 Billion
by Nasdaq info icon info icon
S$0.21 Billion
by CompaniesMarketCap info icon info icon